Daiwa Securities Group
NRXP icon

Daiwa Securities Group’s NRX Pharmaceuticals NRXP Stock Holding History

Daiwa Securities Group’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17
Closed – – 1357
2022
Q3 		$0 Hold
17
– – ﹤0.01% 1368
2022
Q2 		$0 Hold
17
– – ﹤0.01% 1401
2022
Q1 		$0 Hold
17
– – ﹤0.01% 1401
2021
Q4 		$1K Buy
+17
New +$1.23K ﹤0.01% 1346

Other funds holding NRXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Daiwa Securities Group's NRXP Position: Q4 2022 in Review

Daiwa Securities Group sold out of NRX Pharmaceuticals (NRXP) in Q4 2022, closing a stake of 17 shares.

Daiwa Securities Group first reported a position in NRXP in Q4 2021 and held it in 4 quarters. The position peaked at $1K in Q4 2021. 33 funds tracked by Wall St. Rank hold NRXP as of Q4 2022.

  • Daiwa Securities Group reported no remaining NRX Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 17 NRX Pharmaceuticals shares in Q4 2022.
  • Daiwa Securities Group first reported a position in NRX Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Daiwa Securities Group's NRX Pharmaceuticals position peaked at $1K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.